InforSense Limited Collaborates With GlaxoSmithKline (GSK) and Industry Innovators to Enable Virtual Drug Discovery
10/15/2008 8:29:57 AM
LONDON and CAMBRIDGE, MA--(Marketwire - October 15, 2008) - InforSense Ltd., the leading provider of next generation business and scientific intelligence tools, today announced it has successfully completed a pilot project at world leading pharmaceutical company GlaxoSmithKline (GSK) to enable virtual drug discovery through virtual outsourcing of data analysis via secure Grid technology. The project is sponsored by SIMDAT -- a program funded by the European Commission under the Information Society Technologies Programme (IST) designed to test and enhance Grid data technology for product development and production process design.
comments powered by